Aspirin Dosing Considerations In Essential Thrombocythemia: The ARES Trial Overview In patients diagnosed with essential thrombocythemia (ET), the standard treatment involves once-daily low-dose aspirin to mitigate the risk of thrombosis. However, due to accelerated platelet turnover in these patients, the antiplatelet effect of aspirin diminishes over time. A study called the Short-term
Tag: platelet thomboxane
